NCT05295160

Brief Summary

People with a body mass index above 28 kg/m² and an onset of type 2 diabetes within the last 4 years had a remission (HbA1c \<6.5% without medication) of diabetes in over 80% upon weight loss of 15 kg. Longer duration of diabetes reduced the chance of remission. The investigators will test whether there is a difference in remission upon weight loss of 15 kg using formula low calorie diets between subjects with a diabetes duration of \<4 years vs. \>8 years and oral treatment as primary end points. The immune metabolic programming of circulating monocytes will be investigated in detail regarding trained innate immunity and the endocrine responses will be determined using meal challenge tests.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable type-2-diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

September 25, 2020

Completed
1.5 years until next milestone

First Posted

Study publicly available on registry

March 24, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
Last Updated

August 30, 2023

Status Verified

August 1, 2023

Enrollment Period

2.3 years

First QC Date

September 25, 2020

Last Update Submit

August 29, 2023

Conditions

Keywords

type 2 diabetes mellitus in obeseinsulin secretioninnate immunitymonocyte programmingremission of type 2 diabetesweight loss

Outcome Measures

Primary Outcomes (1)

  • Concentration of fasting blood glucose < 126 mg/deciliter

    Remission of type 2 diabetes defined by a concentration of a fasting blood glucose \< 126 mg/deciliter without diabetes medication

    3 month

Secondary Outcomes (2)

  • Immune-metabolic profile and programing of innate immunity

    before, after 7 days and after 3 month

  • Composition of the microbiome

    before, after 7 days and after 3 month

Study Arms (2)

type 2 diabetes - less than 4 years duration

OTHER

Patients with a duration of less than 4 years since diagnosis of type 2 diabetes, BMI \> 28 kg/m², non-insulin treated who agree to loose 15 kg body weight by eating a very low calorie formula diet of 800 kcal/day for men and 600 kcal/day for women. The duration of the diet is until the weight loss is achieved.

Behavioral: weight loss by very low energy diet intake which may differ in protein or carbohydrate content

type 2 diabetes - more than 8 years

OTHER

Patients with a duration of more than 8 years since diagnosis of type 2 diabetes, BMI \> 28 kg/m², non-insulin treated who agree to loose 15 kg body weight by eating a very low calorie formula diet of 800 kcal/day for men and 600 kcal/day for women. The duration of the diet is until the weight loss is achieved.

Behavioral: weight loss by very low energy diet intake which may differ in protein or carbohydrate content

Interventions

The anthropometric, endocrine and metabolic status is tested before, after 7 days and after 15 kg weight loss

type 2 diabetes - less than 4 years durationtype 2 diabetes - more than 8 years

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 2 diabetes diagnosed less than 4 or over 8 years, before study,
  • BMI \> 28 kg/m²,
  • willingness to follow weight loss diet,

You may not qualify if:

  • consuming disease,
  • intolerance for very low calorie formula diet,
  • known severe hepatic disease or liver cirrhosis,
  • type 1 diabetes,
  • severe disease of kidney or heart,
  • advanced diabetic retinopathy,
  • intake of glucocorticoids,
  • drug or alcohol abuse,
  • weight loss of \>5 kg in the last 3 month,
  • eating disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité Campus Benjamin Franklin

Berlin, 12203, Germany

Location

Related Publications (2)

  • Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Stefanetti R, Trenell M, Welsh P, Kean S, Ford I, McConnachie A, Sattar N, Taylor R. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018 Feb 10;391(10120):541-551. doi: 10.1016/S0140-6736(17)33102-1. Epub 2017 Dec 5.

    PMID: 29221645BACKGROUND
  • Steven S, Hollingsworth KG, Al-Mrabeh A, Avery L, Aribisala B, Caslake M, Taylor R. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care. 2016 May;39(5):808-15. doi: 10.2337/dc15-1942. Epub 2016 Mar 21.

    PMID: 27002059BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2ObesityWeight Loss

Interventions

Proteins

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Intervention Hierarchy (Ancestors)

Amino Acids, Peptides, and Proteins

Study Officials

  • Andreas FH Pfeiffer, MD

    Universitätsmedizin Berlin CBF

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Obese people with type 2 diabetes with a duration of less then 4 years will be compared with people with type 2 diabetes for more than 8 years regarding their capability to achieve remission of type 2 diabetes in response to a weight loss of 15kg achived using very low calorie intake
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Professor

Study Record Dates

First Submitted

September 25, 2020

First Posted

March 24, 2022

Study Start

September 25, 2020

Primary Completion

December 31, 2022

Study Completion

April 30, 2023

Last Updated

August 30, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations